Amniotic Fluid-Derived Stem Cells: An Overlooked Source of Stem Cells for Translational Research
DNA and Cell Biology · 2025
DOI: 10.1089/dna.2024.0254 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, 2025. Verfasst von Yu Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: West China Second University Hosptial, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Amniotic Fluid, Translational Research, Biomedical, Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Amniotic fluid-derived stem cells (AFSCs) represent a promising yet underutilized resource for research and clinical applications. While AFSCs share phenotypic and functional characteristics with stem cells derived from somatic tissues such as bone marrow, adipose tissue, placenta, and umbilical cord, their unique developmental origin grants them several superior qualities. These include enhanced multipotency, tissue-specific genotypic profiles, and the ability to form single-cell colonies. Such features position AFSCs as highly valuable for translational research and tissue engineering. This review seeks to underscore the distinctive attributes of AFSCs, particularly their relevance in developmental research and engineering. By emphasizing these qualities, we aim to stimulate further exploration into their use in patient-specific induced pluripotent stem cells and organoid development, potentially unlocking their full therapeutic potential. The unique capabilities of AFSCs make them an exceptional candidate for advancing regenerative medicine, offering new avenues for treating a variety of conditions that currently have limited therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West China Second University Hosptial, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Chengdu, China.
- Yunnan Key Laboratory for Basic Research on Bone and Joint Diseases, Kunming University, Kunming, China.
- Department of Orthopedics, Shenzhen Key Lab of Tissue Engineering, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
- Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen, Guangdong, China.
- R&D Division, Eureka Biotech Inc., Philadelphia, PA, USA.
ORCID-Profile: Bin Jiang
Zitieren
APA
Jiang, Y., Li, Y., Duan, L., & Jiang, B. (2025). Amniotic Fluid-Derived Stem Cells: An Overlooked Source of Stem Cells for Translational Research. DNA and Cell Biology. https://doi.org/10.1089/dna.2024.0254
Vancouver
Jiang Y, Li Y, Duan L, Jiang B. Amniotic Fluid-Derived Stem Cells: An Overlooked Source of Stem Cells for Translational Research. DNA and Cell Biology. 2025. doi:10.1089/dna.2024.0254
BibTeX
@article{Jiang2025,
author = {Jiang, Yu and Li, Yanjiao and Duan, Li and Jiang, Bin},
title = {Amniotic Fluid-Derived Stem Cells: An Overlooked Source of Stem Cells for Translational Research},
journal = {DNA and Cell Biology},
year = {2025},
doi = {10.1089/dna.2024.0254}
}
EUVIMED